A trial of tumour antigen targeted donor T cells in high risk acute myeloid leukaemia
A trial of tumour antigen targeted donor T cells in high risk acute myeloid leukaemia
肿瘤抗原靶向供体 T 细胞治疗高危急性髓系白血病的试验
批准号：
nhmrc : GNT1088118
负责人：
Dr Emily Blyth
金额：
$39.13万
依托单位国家：
澳大利亚
项目类别：
Project Grants
财政年份：
2015
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2015-01-01 至 --
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Acute myeloid leukaemia (AML) is the most common acute leukaemia in adults. Patients with high-risk AML have a 2-year survival of less than 20%. Blood or bone marrow transplant from a healthy donor is often the only chance of cure but the leukaemia frequently returns. We will perform a clinical trial giving leukaemia fighting immune cells from the transplant donor to patients with high risk AML to prevent relapse after transplant.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Patient tailored anti-tumour T cells to prevent relapse in patients with acute myeloid leukaemia undergoing allogeneic haemopoietic stem cell transplantation
-
批准号：nhmrc : GNT1089398
-
项目类别：Early Career Fellowships
-
资助金额：$18.47万
-
财政年份：2015
-
负责人：Dr Emily Blyth
-
依托单位：
Patient tailored anti-tumour T cells to prevent relapse in patients with acute myeloid leukaemia undergoing allogeneic haemopoietic stem cell transplantation
-
批准号：nhmrc : 1089398
-
项目类别：Early Career Fellowships
-
资助金额：$12.7万
-
财政年份：2015
-
负责人：Dr Emily Blyth
-
依托单位：
A trial of tumour antigen targeted donor T cells in high risk acute myeloid leukaemia
-
批准号：nhmrc : 1088118
-
项目类别：Project Grants
-
资助金额：$26.94万
-
财政年份：2015
-
负责人：Dr Emily Blyth
-
依托单位：
国内基金
海外基金
美洲大蠊有效成分抗肿瘤作用及其机制研究
-
批准号：30860337
-
项目类别：地区科学基金项目
-
资助金额：24.0万元
-
批准年份：2008
-
负责人：彭芳
-
依托单位：
